[
    {
        "document": "Marion Leboyer",
        "metadata": {
            "originalPdf": "eac9624b-65fe-412f-b7ab-f9ea82581e16.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "33"
    },
    {
        "document": "Université Paris Est Creteil (UPEC)",
        "metadata": {
            "originalPdf": "eac9624b-65fe-412f-b7ab-f9ea82581e16.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "34"
    },
    {
        "document": "AP-HP",
        "metadata": {
            "originalPdf": "eac9624b-65fe-412f-b7ab-f9ea82581e16.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "35"
    },
    {
        "document": "Hôpitaux Universitaires ”H. Mondor ”",
        "metadata": {
            "originalPdf": "eac9624b-65fe-412f-b7ab-f9ea82581e16.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "36"
    },
    {
        "document": "INSERM",
        "metadata": {
            "originalPdf": "eac9624b-65fe-412f-b7ab-f9ea82581e16.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "38"
    },
    {
        "document": "Fondation FondaMental",
        "metadata": {
            "originalPdf": "eac9624b-65fe-412f-b7ab-f9ea82581e16.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "41"
    },
    {
        "document": "8, rue du Général Sarrail",
        "metadata": {
            "originalPdf": "eac9624b-65fe-412f-b7ab-f9ea82581e16.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "42"
    },
    {
        "document": "Creteil",
        "metadata": {
            "originalPdf": "eac9624b-65fe-412f-b7ab-f9ea82581e16.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "44"
    },
    {
        "document": "Marion Leboyer",
        "metadata": {
            "originalPdf": "Disruption of circadian rhythm and risk of autism spectrum disorder.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "309"
    },
    {
        "document": "Université Paris Est Creteil (UPEC)",
        "metadata": {
            "originalPdf": "Disruption of circadian rhythm and risk of autism spectrum disorder.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "310"
    },
    {
        "document": "AP-HP",
        "metadata": {
            "originalPdf": "Disruption of circadian rhythm and risk of autism spectrum disorder.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "311"
    },
    {
        "document": "Hôpitaux Universitaires ”H. Mondor ”",
        "metadata": {
            "originalPdf": "Disruption of circadian rhythm and risk of autism spectrum disorder.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "312"
    },
    {
        "document": "INSERM",
        "metadata": {
            "originalPdf": "Disruption of circadian rhythm and risk of autism spectrum disorder.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "314"
    },
    {
        "document": "Fondation FondaMental",
        "metadata": {
            "originalPdf": "Disruption of circadian rhythm and risk of autism spectrum disorder.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "317"
    },
    {
        "document": "8, rue du Général Sarrail",
        "metadata": {
            "originalPdf": "Disruption of circadian rhythm and risk of autism spectrum disorder.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "318"
    },
    {
        "document": "Creteil",
        "metadata": {
            "originalPdf": "Disruption of circadian rhythm and risk of autism spectrum disorder.pdf",
            "originalText": " Thycaud Post, Poojappura, Trivandrum,695014, Kerala, IndiaMichael Berk, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; and Orygen, The Centre of Excellence in Youth MentalHealth, The Department of Psychiatry, The Florey Institute of\nNeuroscience and Mental Health, The University of Melbourne, 30\nRoyal Parade, Parkville, Victoria, 3052, AustraliaMichael Maes, School of Medicine, IMPACT Strategic Research Centre,\nDeakin University, Barwon Health, PO Box 281, Geelong, Victoria,\n3220, Australia; Department of Psychiatry, Faculty of Medicine, KingChulalongkorn Memorial Hospital, Pathum Wan, Pathum Wan District,\nBangkok, 10330, Thailand; and Department of Psychiatry, Medical\nUniversity of Plovdiv, bul. “Vasil Aprilov ”15A, 4002 Tsetar, Plovdiv,\nBulgariaMarion Leboyer, Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux\nUniversitaires ”H. Mondor ”, DMU IMPACT, INSERM, IMRB,\nTranslational Neuropsychiatry, Fondation FondaMental, 8, rue duGénéral Sarrail, 94010, Creteil, FranceRev. Neurosci. 2021; aop",
            "page": 0
        },
        "id": "320"
    },
    {
        "document": "B. Auguié",
        "metadata": {
            "originalPdf": "10c5984f-d755-4b18-be0b-84d66e2cdd8a.pdf",
            "originalText": "A.Atwater,A.Polman, Nat.Mater. 2010,9,205.\n[6] J.Langer,D.JimenezDeAberasturi,J.Aizpurua,R.A.Alvarez-Puebla,\nB. Auguié, J. J. Baumberg, G. C. Bazan, S. E. J. Bell, A. Boisen, A. G.\nBrolo, J. Choo, D. Cialla-May, V. Deckert, L. Fabris, K. Faulds, F. J.\nGarcíaDeAbajo,R.Goodacre,D.Graham,A.J.Haes,C.L.Haynes,\nC. Huck, T. Itoh, M. Käll, J. Kneipp, N. A. Kotov, H. Kuang, E. C. Le\nRu,H.K.Lee,J.-F.Li,X.Y.Ling,etal., ACSNano 2020,14,28.\n[7] B. Sharma, R. R. Frontiera, A.-I. Henry, E. Ringe, R. P. Van Duyne,\nMater.Today 2012,15,16.\n[8] N. Liu, M. Mesch, T. Weiss, M. Hentschel, H. Giessen, Nano Lett.\n2010,10,2342.\n[9] J. N. Anker, W. P. Hall, O. Lyandres, N. C. Shah, J. Zhao, R. P. Van\nDuyne,Nat.Mater. 2008,7,442.\n[10] K. C. Bantz, A. F. Meyer, N. J. Wittenberg, H. Im, Ö. Kurtulus, S. H.\nLee,N.C.Lindquist,S.-H.Oh,C.L.Haynes, Phys.Chem.Chem.Phys.\n2011,13,11551.\n[11] R.Bardhan,S.Lal,A.Joshi,N.J.Halas, Acc.Chem.Res. 2011,44,936.\n[12] O. Neumann, A. S. Urban, J. Day, S. Lal, P. Nordlander, N. J. Halas,\nACSNano 2013,7,42.\n[13] J.G.Smith,J.A.Faucheaux,P.K.Jain, NanoToday 2015,10,67.\n[14] L. Zhou, Y. Tan, J. Wang, W. Xu, Y. Yuan, W. Cai, S. Zhu, J. Zhu, Nat.\nPhotonics2016,10,393.\n[15] S.Linic,P.Christopher,D.B.Ingram, Nat.Mater. 2011,10,911.\n[16] Z. Zheng, W. Xie, B. Huang, Y. Dai, Chem., A Eur. J. 2018,24,\n18322.\n[17] P. R. West, S. Ishii, G. V. Naik, N. K. Emani, V. M. Shalaev, A.\nBoltasseva, LaserPhoton.Rev. 2010,4,795.\n[18] G.V.Naik,V.M.Shalaev,A.Boltasseva, Adv.Mater. 2013,25,3264.\n[19] W.A.Murray,W.L.Barnes, Adv.Mater. 2007,19,3771.\n[20] Y.Cui,A.Lauchner,A.Manjavacas,F.J.GarcíaDeAbajo,N.J.Halas,\nP.Nordlander, NanoLett. 2016,16,6390.\n[21] A.Lauchner,A.E.Schlather,A.Manjavacas,Y.Cui,M.J.Mcclain,G.\nJ. Stec, F. J. García De Abajo, P. Nordlander, N. J. Halas, Nano Lett.\n2015,15,6208.\n[22] T.-C.Hung,B.Kiraly,J.H.Strik,A.A.Khajetoorians,D.Wegner, Nano\nLett.20",
            "page": 11
        },
        "id": "2209"
    },
    {
        "document": "F.Fournier",
        "metadata": {
            "originalPdf": "10c5984f-d755-4b18-be0b-84d66e2cdd8a.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "2368"
    },
    {
        "document": "S.Desobry",
        "metadata": {
            "originalPdf": "10c5984f-d755-4b18-be0b-84d66e2cdd8a.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "2369"
    },
    {
        "document": "Bellissant E",
        "metadata": {
            "originalPdf": "4a98b445-1f09-4a39-8425-dd23b7140e64.pdf",
            "originalText": "/wake and neuroinflammatory effects of methamphetamine. Brain Behav Immun 2011; 25(4): 767-76.  [http://dx.doi.org/10.1016/j.bbi.2011.02.002] [PMID: 21333736] [150] Malow BA, McGrew SG. Sleep and quality of life in autism.Sleep and quality of life in medical illness 2008; 221-7.  [http://dx.doi.org/10.1007/978-1-60327-343-5_24] [151] Johnson CR, Smith T, DeMand A, et al. Exploring sleep quality of young children with autism spectrum disorder and disruptive be-haviors. Sleep Med 2018; 44: 61-6.  [http://dx.doi.org/10.1016/j.sleep.2018.01.008] [PMID: 29530371] [152] Turygin N, Matson JL, Tureck K. ADHD symptom prevalence and risk factors in a sample of toddlers with ASD or who are at risk for developmental delay. Res Dev Disabil 2013; 34(11): 4203-9.  [http://dx.doi.org/10.1016/j.ridd.2013.07.020] [PMID: 24077069] [153] da Silveira Cruz-Machado S, Guissoni Campos LM, Fadini CC, Anderson G, Markus RP, Pinato L. Disrupted nocturnal melatonin rhythm in Autism: correlation with TNF and sleep disturbances submitted [154] Muscatello RA, Corbett BA. Comparing the effects of age, pubertal development, and symptom profile on cortisol rhythm in children and adolescents with autism spectrum disorder. Autism Res 2018; 11(1): 110-20.  [http://dx.doi.org/10.1002/aur.1879] [PMID: 29030905] [155] Tordjman S, Najjar I, Bellissant E, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci 2013; 14(10): 20508-42.  [http://dx.doi.org/10.3390/ijms141020508] [PMID: 24129182] [156] Nir I, Meir D, Zilber N, Knobler H, Hadjez J, Lerner Y. Brief re-port: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev Disord 1995; 25(6): 641-54.  [http://dx.doi.org/10.1007/BF02178193] [PMID: 8720032] [157] Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 2006; 32(5): 585-9.  [http://dx.doi.org/10.1111/j.1365-2214.2006.00616.x] [PMID: 16919138] [158] Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 2006; 27(3): 254-89.  [http://dx.doi.org/10.1016/j.ridd.2005.03.003] [PMID: 16002261] [159] Kulman G, Lissoni P, Rovelli F, Roselli MG, Brivio F, Sequeri P. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol Lett 2000; 21(1): 31-4.  [PMID: 11455326] [160] Braam W, Ehrhart F, Maas APHM, Smits MG, Curfs L. Low ma-ternal melatonin level increases autism spectrum disorder risk in children. Res Dev Disabil 2018; 82: 79-89.  [http://dx.doi.org/10.1016/j.ridd.2018.02.017] [PMID: 29501372] [161] Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 2011; 53(9): 783-92.  [http://dx.doi.org/10.1111/j.1469-8749.2011.03980.x] [PMID: 21518346] [162] Johansson AEE, Dorman",
            "page": 13
        },
        "id": "3511"
    },
    {
        "document": "Bellissant",
        "metadata": {
            "originalPdf": "4a98b445-1f09-4a39-8425-dd23b7140e64.pdf",
            "originalText": "/wake and neuroinflammatory effects of methamphetamine. Brain Behav Immun 2011; 25(4): 767-76.  [http://dx.doi.org/10.1016/j.bbi.2011.02.002] [PMID: 21333736] [150] Malow BA, McGrew SG. Sleep and quality of life in autism.Sleep and quality of life in medical illness 2008; 221-7.  [http://dx.doi.org/10.1007/978-1-60327-343-5_24] [151] Johnson CR, Smith T, DeMand A, et al. Exploring sleep quality of young children with autism spectrum disorder and disruptive be-haviors. Sleep Med 2018; 44: 61-6.  [http://dx.doi.org/10.1016/j.sleep.2018.01.008] [PMID: 29530371] [152] Turygin N, Matson JL, Tureck K. ADHD symptom prevalence and risk factors in a sample of toddlers with ASD or who are at risk for developmental delay. Res Dev Disabil 2013; 34(11): 4203-9.  [http://dx.doi.org/10.1016/j.ridd.2013.07.020] [PMID: 24077069] [153] da Silveira Cruz-Machado S, Guissoni Campos LM, Fadini CC, Anderson G, Markus RP, Pinato L. Disrupted nocturnal melatonin rhythm in Autism: correlation with TNF and sleep disturbances submitted [154] Muscatello RA, Corbett BA. Comparing the effects of age, pubertal development, and symptom profile on cortisol rhythm in children and adolescents with autism spectrum disorder. Autism Res 2018; 11(1): 110-20.  [http://dx.doi.org/10.1002/aur.1879] [PMID: 29030905] [155] Tordjman S, Najjar I, Bellissant E, et al. Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives. Int J Mol Sci 2013; 14(10): 20508-42.  [http://dx.doi.org/10.3390/ijms141020508] [PMID: 24129182] [156] Nir I, Meir D, Zilber N, Knobler H, Hadjez J, Lerner Y. Brief re-port: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev Disord 1995; 25(6): 641-54.  [http://dx.doi.org/10.1007/BF02178193] [PMID: 8720032] [157] Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 2006; 32(5): 585-9.  [http://dx.doi.org/10.1111/j.1365-2214.2006.00616.x] [PMID: 16919138] [158] Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 2006; 27(3): 254-89.  [http://dx.doi.org/10.1016/j.ridd.2005.03.003] [PMID: 16002261] [159] Kulman G, Lissoni P, Rovelli F, Roselli MG, Brivio F, Sequeri P. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol Lett 2000; 21(1): 31-4.  [PMID: 11455326] [160] Braam W, Ehrhart F, Maas APHM, Smits MG, Curfs L. Low ma-ternal melatonin level increases autism spectrum disorder risk in children. Res Dev Disabil 2018; 82: 79-89.  [http://dx.doi.org/10.1016/j.ridd.2018.02.017] [PMID: 29501372] [161] Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 2011; 53(9): 783-92.  [http://dx.doi.org/10.1111/j.1469-8749.2011.03980.x] [PMID: 21518346] [162] Johansson AEE, Dorman",
            "page": 13
        },
        "id": "3540"
    },
    {
        "document": "PSG",
        "metadata": {
            "originalPdf": "bb4792cf-e9cb-49bf-89db-c5479abb5a2c.pdf",
            "originalText": ". \nWith the brief duration of exposure to each individual light flash, there may be an insufficient number of retinal \n(ipRGC) circuits activated for some of the flashes. This could lead to discontinuity in the flash signal (i.e., ipRGC \ncould stop signaling continuously), which reduces the impact of the flashes on the circadian  clock16.\nExposure to a sequence of light flashes during wake can be an aversive experience. Thus, light flashes have \npreviously been used in field studies of individuals while they are  asleep20. This is also at the time during which \nthe circadian clock is most sensitive to  light9,28. To be useful in the field, however, the light flashes must not \nactively interfere with sleep. In one previous study, we found no evidence for a different sequence of light flashes \nto interfere with PSG-recorded  sleep18. In the current study, PSG indicated no substantive differences between \nsham and flash therapy in sleep quality and architecture. We examined PSG using traditional scoring meth-\nods, spectral analysis, and sleep state probability analysis. We were unable to observe significant differences in \nsleep architecture and probability scoring due to the flashes. Despite our potential lack of statistical power to \nidentify subtle changes in flash-induced sleep architecture or power, we did have the capability to detect gross \ndisturbances in sleep, with an accuracy threshold of 4.8 min of wakefulness or more. However, we did find some \nevidence for small flash-induced changes in the number of transitions from sleep to wake and deep to light sleep, \nand an enhancement of delta activity in the light flash condition. This delta enhancement is likely secondary to \nan evoked response rather than a true induction of delta  activity18. In one participant, there was much more wake \nduring the 1-h light flash exposure, however, this participant was awake prior to the onset of the light flashes and \nthe presence of the light flashes likely made falling asleep very difficult (they did go to sleep after cessation of \nthe flashes). The light flash sequence was administered at the beginning of the sleep period, so under the high -\nest homeostatic pressure, which may have reduced the likelihood of the flashes causing an acute arousal. In one \nprevious field study in adolescents, light flashes were administered at the end of the sleep period, during which \nthere was greatly reduced homeostatic pressure, and yet no self-reported evidence of sleep disruption when the \nduration of the light flash exposure was limited to 2   h20. The impact of light flashes on sleep architecture and \nspectral power reported here and in previous  studies18 appears to be relatively modest; nonetheless, it’s important \nto approach the safety assessment of short (1 h) exposure flash therapy with care. Moderate-intensity continuous \nlight (100 lx) given throughout sleep has been shown to potentially have adverse effects on  health29, while lower \nintensity (40 lx) given throughout the night can affect sleep architecture and spectral  power30.\nBy placing light flashes near the beginning of sleep, the light flashes were predominantly administrated during \nN2 and N3 sleep, with very little wake, N1, or REM occurring (Fig.  2). With the limited range of sleep stages, we \ndid not observe any direct interaction between sleep stage and the magnitude of phase shift elicited by the light \nflashes. Sleep can directly impact the electrophysiologic characteristics of the SCN and, in theory, could change \nthe response of the SCN to the light flash  stimuli31. Experiments with shorter-duration stimuli that are proactively \nassigned to be administered during specific stages of sleep would be needed to answer this question definitively.\nLimitations of real-world implications arise from certain aspects of our study design. Firstly, participants were \nsubjected to a 2-week circadian stabilization period with regular bed and wake times. The regular light exposure \nthat occurs with this type of sleep–wake schedule maximizes the circadian clock’s oscillation amplitude. This \ndeliberate setup effectively targeted the phase delay part of the phase response curve. However, without such \ncircadian phase stabilization, achieving precise targeting of the correct phase becomes challenging, potentially ",
            "page": 4
        },
        "id": "3663"
    },
    {
        "document": "B. Auguié",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "A.Atwater,A.Polman, Nat.Mater. 2010,9,205.\n[6] J.Langer,D.JimenezDeAberasturi,J.Aizpurua,R.A.Alvarez-Puebla,\nB. Auguié, J. J. Baumberg, G. C. Bazan, S. E. J. Bell, A. Boisen, A. G.\nBrolo, J. Choo, D. Cialla-May, V. Deckert, L. Fabris, K. Faulds, F. J.\nGarcíaDeAbajo,R.Goodacre,D.Graham,A.J.Haes,C.L.Haynes,\nC. Huck, T. Itoh, M. Käll, J. Kneipp, N. A. Kotov, H. Kuang, E. C. Le\nRu,H.K.Lee,J.-F.Li,X.Y.Ling,etal., ACSNano 2020,14,28.\n[7] B. Sharma, R. R. Frontiera, A.-I. Henry, E. Ringe, R. P. Van Duyne,\nMater.Today 2012,15,16.\n[8] N. Liu, M. Mesch, T. Weiss, M. Hentschel, H. Giessen, Nano Lett.\n2010,10,2342.\n[9] J. N. Anker, W. P. Hall, O. Lyandres, N. C. Shah, J. Zhao, R. P. Van\nDuyne,Nat.Mater. 2008,7,442.\n[10] K. C. Bantz, A. F. Meyer, N. J. Wittenberg, H. Im, Ö. Kurtulus, S. H.\nLee,N.C.Lindquist,S.-H.Oh,C.L.Haynes, Phys.Chem.Chem.Phys.\n2011,13,11551.\n[11] R.Bardhan,S.Lal,A.Joshi,N.J.Halas, Acc.Chem.Res. 2011,44,936.\n[12] O. Neumann, A. S. Urban, J. Day, S. Lal, P. Nordlander, N. J. Halas,\nACSNano 2013,7,42.\n[13] J.G.Smith,J.A.Faucheaux,P.K.Jain, NanoToday 2015,10,67.\n[14] L. Zhou, Y. Tan, J. Wang, W. Xu, Y. Yuan, W. Cai, S. Zhu, J. Zhu, Nat.\nPhotonics2016,10,393.\n[15] S.Linic,P.Christopher,D.B.Ingram, Nat.Mater. 2011,10,911.\n[16] Z. Zheng, W. Xie, B. Huang, Y. Dai, Chem., A Eur. J. 2018,24,\n18322.\n[17] P. R. West, S. Ishii, G. V. Naik, N. K. Emani, V. M. Shalaev, A.\nBoltasseva, LaserPhoton.Rev. 2010,4,795.\n[18] G.V.Naik,V.M.Shalaev,A.Boltasseva, Adv.Mater. 2013,25,3264.\n[19] W.A.Murray,W.L.Barnes, Adv.Mater. 2007,19,3771.\n[20] Y.Cui,A.Lauchner,A.Manjavacas,F.J.GarcíaDeAbajo,N.J.Halas,\nP.Nordlander, NanoLett. 2016,16,6390.\n[21] A.Lauchner,A.E.Schlather,A.Manjavacas,Y.Cui,M.J.Mcclain,G.\nJ. Stec, F. J. García De Abajo, P. Nordlander, N. J. Halas, Nano Lett.\n2015,15,6208.\n[22] T.-C.Hung,B.Kiraly,J.H.Strik,A.A.Khajetoorians,D.Wegner, Nano\nLett.20",
            "page": 11
        },
        "id": "4016"
    },
    {
        "document": "F.Fournier",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "4186"
    },
    {
        "document": "S.Desobry",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "4187"
    },
    {
        "document": "G.Duret",
        "metadata": {
            "originalPdf": "Advanced Materials - 2024.pdf",
            "originalText": "www.advancedsciencenews.com www.advmat.de\n[34] L.Shao,C.Fang,H.Chen,Y. C.Man,J.Wang,H.-Q.Lin, Nano Lett.\n2012,12,1424.\n[35] A. Mishra, R. K. Behera, P. K. Behera, B. K. Mishra, G. B. Behera,\nChem.Rev. 2000,100,1973.\n[36] C.Shi,J.B.Wu,D.Pan, J.Biomed.Opt. 2016,21,050901.\n[37] M. Falabella, H. J. Vernon, M. G. Hanna, S. M. Claypool, R. D. S.\nPitceathly, TrendsEndocrinol.Metab. 2021,32,224.\n[38] H.H.Szeto, Br.J.Pharmacol. 2014,171,2029.\n[39] A. J. Chicco, G. C. Sparagna, Am. J. Physiol., Cell Physiol. 2007,292,\nC33.\n[40] J.Sangster, J.Phys.Chem.Ref.Data 2009,18,1111.\n[41] E.A.Tehrany,F.Fournier,S.Desobry, J.FoodEng. 2004,64,315.\n[42] G.Majno,I.Joris, Am.J.Pathol. 1995,146,3.\n[43] S.L.Fink,B.T.Cookson, Infect.Immun. 2005,73,1907.[44] R. Zhang, L. Bursi, J. D. Cox, Y. Cui, C. M. Krauter, A. Alabastri, A.\nManjavacas,A.Calzolari,S.Corni,E.Molinari,E.A.Carter,F.J.García\nDeAbajo,H.Zhang,P.Nordlander, ACSNano 2017,11,7321.\n[45] L. Bursi, A. Calzolari, S. Corni, E. Molinari, ACS Photonics 2016,3,\n520.\n[46] A.L.Santos,D.Liu,A.K.Reed,A.M.Wyderka,A.VanVenrooy,J.T.Li,\nV. D. Li, M. Misiura, O. Samoylova, J. L. Beckham, C. Ayala-Orozco,\nA.B.Kolomeisky,L.B.Alemany,A.Oliver,G.P.Tegos,J.M.Tour, Sci.\nAdv.2022,8,eabm2055.\n[47] A. L. Santos, J. L. Beckham, D. Liu, G. Li, A. Van Venrooy, A. Oliver,\nG.P.Tegos,J.M.Tour, Adv.Sci.2023,10,2205781.\n[48] J. L. Beckham, A. R. Van Venrooy, S. Kim, G. Li, B. Li, G. Duret,\nD. Arnold, X. Zhao, J. T. Li, A. L. Santos, G. Chaudhry, D. Liu, J. T.\nRobinson,J.M.Tour, Nat.Nanotechnol. 2023,18,1051.\nAdv. Mater. 2024,2309910 ©2024Wiley-VCHGmbH 2309910(13of13)\n 15214095, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/adma.202309910 by Jinhee Kim - South Korea National Provision , Wiley Online Library on [08/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License\n",
            "page": 12
        },
        "id": "4249"
    },
    {
        "document": "PSG",
        "metadata": {
            "originalPdf": "s41598-023-41742-w.pdf",
            "originalText": ". \nWith the brief duration of exposure to each individual light flash, there may be an insufficient number of retinal \n(ipRGC) circuits activated for some of the flashes. This could lead to discontinuity in the flash signal (i.e., ipRGC \ncould stop signaling continuously), which reduces the impact of the flashes on the circadian  clock16.\nExposure to a sequence of light flashes during wake can be an aversive experience. Thus, light flashes have \npreviously been used in field studies of individuals while they are  asleep20. This is also at the time during which \nthe circadian clock is most sensitive to  light9,28. To be useful in the field, however, the light flashes must not \nactively interfere with sleep. In one previous study, we found no evidence for a different sequence of light flashes \nto interfere with PSG-recorded  sleep18. In the current study, PSG indicated no substantive differences between \nsham and flash therapy in sleep quality and architecture. We examined PSG using traditional scoring meth-\nods, spectral analysis, and sleep state probability analysis. We were unable to observe significant differences in \nsleep architecture and probability scoring due to the flashes. Despite our potential lack of statistical power to \nidentify subtle changes in flash-induced sleep architecture or power, we did have the capability to detect gross \ndisturbances in sleep, with an accuracy threshold of 4.8 min of wakefulness or more. However, we did find some \nevidence for small flash-induced changes in the number of transitions from sleep to wake and deep to light sleep, \nand an enhancement of delta activity in the light flash condition. This delta enhancement is likely secondary to \nan evoked response rather than a true induction of delta  activity18. In one participant, there was much more wake \nduring the 1-h light flash exposure, however, this participant was awake prior to the onset of the light flashes and \nthe presence of the light flashes likely made falling asleep very difficult (they did go to sleep after cessation of \nthe flashes). The light flash sequence was administered at the beginning of the sleep period, so under the high -\nest homeostatic pressure, which may have reduced the likelihood of the flashes causing an acute arousal. In one \nprevious field study in adolescents, light flashes were administered at the end of the sleep period, during which \nthere was greatly reduced homeostatic pressure, and yet no self-reported evidence of sleep disruption when the \nduration of the light flash exposure was limited to 2   h20. The impact of light flashes on sleep architecture and \nspectral power reported here and in previous  studies18 appears to be relatively modest; nonetheless, it’s important \nto approach the safety assessment of short (1 h) exposure flash therapy with care. Moderate-intensity continuous \nlight (100 lx) given throughout sleep has been shown to potentially have adverse effects on  health29, while lower \nintensity (40 lx) given throughout the night can affect sleep architecture and spectral  power30.\nBy placing light flashes near the beginning of sleep, the light flashes were predominantly administrated during \nN2 and N3 sleep, with very little wake, N1, or REM occurring (Fig.  2). With the limited range of sleep stages, we \ndid not observe any direct interaction between sleep stage and the magnitude of phase shift elicited by the light \nflashes. Sleep can directly impact the electrophysiologic characteristics of the SCN and, in theory, could change \nthe response of the SCN to the light flash  stimuli31. Experiments with shorter-duration stimuli that are proactively \nassigned to be administered during specific stages of sleep would be needed to answer this question definitively.\nLimitations of real-world implications arise from certain aspects of our study design. Firstly, participants were \nsubjected to a 2-week circadian stabilization period with regular bed and wake times. The regular light exposure \nthat occurs with this type of sleep–wake schedule maximizes the circadian clock’s oscillation amplitude. This \ndeliberate setup effectively targeted the phase delay part of the phase response curve. However, without such \ncircadian phase stabilization, achieving precise targeting of the correct phase becomes challenging, potentially ",
            "page": 4
        },
        "id": "4387"
    }
]